BizWest – Boulder has a track record of being home to life-science startups that succeed in making discoveries by tapping into local talent and research at universities, only to have the startups move away or be acquired by larger biopharma companies as they move into drug development and then commercialization.
“Boulder remains a niche player in life sciences,” said Kyle Lefkoff, founder and general partner of Boulder Ventures Ltd. and chairman of Boulder-based Array BioPharma Inc. Read more…